Overcoming challenges in long-lasting pediatric clinical trials – Insights from site experts
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Kayentis Media Player, for informed and engaged patients in clinical trials
Patients taking part in clinical trials need clear and simple information – this is what 70% of 1,133 survey participants told us during our clinical study patients survey. Moreover, it is well known that providing both clear information and helpful technology to clinical trial participants is key. This supports patients throughout a clinical trial, helping them to feel more involved, as well as providing clear evidence of the value of the data they generously give, reminding them of the importance of compliance to trial procedures, and reducing the study burden.
But how can clinical trial patients be given the information they need? How can they be sure to have access to relevant information easily in times of clinical trial digitalization and decentralization? At Kayentis, we have embedded a simple and efficient media player in our eCOA solution – the Kayentis Media Player (KMP) – that allows relevant information to be provided regularly through very user-friendly technology.
The KMP is a very easy-to-use app that can display documents and resources for immediate use by patients. Using the KMP makes a lot of sense in various circumstances.
Patients would probably be more inclined to join and complete clinical trials if they are sufficiently and clearly informed. Only an informed patient can be one who properly understands the reasons for conducting clinical research, the value of the data collected, and the importance of compliance. Sharing simple and appropriate information is now seen as contributing to a clinical trial’s success, and the clinical trials industry must create simple and appropriate tools to convey this information.
Learn more:
In this third episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Integrating PROs into studies on MASH is crucial. NASH is a debilitating chronic illness that significantly
Asthma clinical trials present several specificities, such as the use of disease-specific health-related quality of
NonAlcoholic SteatoHepatitis (NASH), now called Metabolic Dysfunction-Associated SteatoHepatitis (MASH), affects almost 115 million adults globally
In this second episode on pediatric clinical trial challenges, Begoña Nafria, pediatrician and patient engagement
Ophthalmic conditions and vision impairment currently affect 2.2 billion people globally. Data collection can be
Last update : 31 May 2022